SEBI Debarred Entities
The SEBI debarred entities list includes individuals and organizations that have been prohibited by the securities and exchange board of India (SEBI) from participating in securities markets. This action is typically taken due to violations of regulatory guidelines or laws related to securities trading and investment.
Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
11,559 Entities in SEBI Debarred Entities
Entity Name | Entity Type | Effective Date | Status |
---|---|---|---|
Shiv pravesh chaturvedi | Company | May 31, 2023 | inactive |
Harvinder singh | Company | Jan 15, 2021 | inactive |
Rana veer pratap singh | Company | Jan 31, 2020 | inactive |
Abhijeet chandrahas asai | Company | Jan 25, 2019 | inactive |
Parveen kumar jain | Company | May 31, 2023 | inactive |
Amar sarin | Company | Dec 21, 2021 | inactive |
Kamal agrawal | Company | Feb 28, 2022 | inactive |
Pramod broota | Company | Feb 17, 2023 | inactive |
Sushila sarda | Individual | Nov 28, 2024 | active |
Shome shankar ray | Company | Jul 31, 2017 | active |
FAQs
Why is compliance with the Sanctioned Providers by The Defense Health Agency of United States (DHA) necessary?
Compliance with the Sanctioned Providers List published by the Defense Health Agency (DHA) is crucial for maintaining the integrity and security of healthcare services. These sanctions are implemented to protect beneficiaries from entities that may engage in fraudulent or unsafe practices. Adherence ensures that healthcare providers are not only meeting legal and regulatory standards but also safeguarding public health. Failing to comply can result in serious legal implications, financial penalties, and a diminished quality of care for those who rely on DHA services.
Which companies should comply with Sanctioned Providers by The Defense Health Agency of United States (DHA)?
The Sanctioned Providers List by the Defense Health Agency (DHA) primarily impacts healthcare organizations, including hospitals, clinics, and pharmaceutical companies. These entities must comply to ensure they do not engage with individuals or organizations that pose risks to patient safety or violate federal regulations. Compliance protects public health and maintains the integrity of the healthcare system while avoiding legal repercussions.
APIs
Data License
Solutions
Pricing